Rodent Models for Investigating the Dysregulation of Immune Responses in Type 1 Diabetes
Author(s) -
FengCheng Chou,
Heng-Yi Chen,
ShyiJou Chen,
Mei-Cho Fang,
HueyKang Sytwu
Publication year - 2013
Publication title -
journal of diabetes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.034
H-Index - 50
eISSN - 2314-6753
pISSN - 2314-6745
DOI - 10.1155/2013/138412
Subject(s) - nod , autoimmunity , transgene , nod mice , pathogenesis , genetically modified mouse , knockout mouse , conditional gene knockout , immunology , type 1 diabetes , immune system , diabetes mellitus , gene knockout , rodent , biology , disease , autoimmune disease , animal model , immune dysregulation , gene knockin , genetics , gene , medicine , antibody , phenotype , endocrinology , ecology
Type 1 diabetes (T1D) is an autoimmune disease mediated by T cells that selectively destroy the insulin-producing β cells. Previous reports based on epidemiological and animal studies have demonstrated that both genetic factors and environmental parameters can either promote or attenuate the progression of autoimmunity. In recent decades, several inbred rodent strains that spontaneously develop diabetes have been applied to the investigation of the pathogenesis of T1D. Because the genetic manipulation of mice is well developed (transgenic, knockout, and conditional knockout/transgenic), most studies are performed using the nonobese diabetic (NOD) mouse model. This paper will focus on the use of genetically manipulated NOD mice to explore the pathogenesis of T1D and to develop potential therapeutic approaches.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom